A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Clinical trial NCT05748171 · RECRUITING

Trial details

NCT number: NCT05748171
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ACUTE LYMPHOBLASTIC LEUKEMIA

Start date: 2023-05-17
Primary completion: 2033-05-21
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.